Recommendations	O
for	O
cerebrospinal	B:C0007806
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
dementia	O
.	O

Recommendations	O
for	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
biomarkers	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
dementia	O
.	O

Recommendations	O
for	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	B:C0005516
in	O
the	O
diagnostic	O
evaluation	O
of	O
dementia	O
.	O

Recommendations	O
for	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
in	O
the	O
diagnostic	B:C0430022
evaluation	O
of	O
dementia	O
.	O

Recommendations	O
for	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
in	O
the	O
diagnostic	O
evaluation	B:C0220825
of	O
dementia	O
.	O

Recommendations	O
for	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
dementia	B:C0497327
.	O

This	O
article	B:C1706852
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	B:C0441800
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	B:C0220825
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	B:C2911685
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	B:C4084924
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	B:C0007806
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	B:C0007806
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	B:C0169424
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	B:C0085401
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	B:C1519061
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	B:C0085401
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	B:C0430022
evaluation	O
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	B:C0220825
of	O
patients	O
with	O
dementia	O
.	O

This	O
article	O
presents	O
recommendations	O
,	O
based	O
on	O
the	O
Grading	O
of	O
Recommendations	O
,	O
Assessment	O
,	O
Development	O
,	O
and	O
Evaluation	O
method	I:C2911685
,	O
for	O
the	O
clinical	O
application	I:C4084924
of	O
cerebrospinal	O
fluid	I:C0007806
(	O
cerebrospinal	O
fluid	I:C0007806
)	O
amyloid	O
-	I:C0169424
β1	I:C0169424
-	I:C0169424
42	I:C0169424
,	O
tau	O
,	O
and	O
phosphorylated	O
tau	O
in	O
the	O
diagnostic	O
evaluation	O
of	O
patients	O
with	O
dementia	B:C0497327
.	O

The	O
recommendations	O
were	O
developed	O
by	O
a	O
multidisciplinary	O
working	B:C1883562
group	I:C1883562
based	O
on	O
the	O
available	O
evidence	O
and	O
consensus	O
from	O
focused	O
discussions	O
for	O
(	O
i	O
)	O
identification	O
of	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
as	O
the	O
cause	O
of	O
dementia	O
,	O
(	O
ii	O
)	O
prediction	O
of	O
rate	O
of	O
decline	O
,	O
(	O
iii	O
)	O
cost	O
-	O
effectiveness	O
,	O
and	O
(	O
iv	O
)	O
interpretation	O
of	I:C3526596
results	I:C3526596
.	O

The	O
recommendations	O
were	O
developed	O
by	O
a	O
multidisciplinary	O
working	O
group	I:C1883562
based	O
on	O
the	O
available	O
evidence	O
and	O
consensus	O
from	O
focused	O
discussions	O
for	O
(	O
i	O
)	O
identification	O
of	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
as	O
the	O
cause	O
of	O
dementia	O
,	O
(	O
ii	O
)	O
prediction	O
of	O
rate	O
of	O
decline	O
,	O
(	O
iii	O
)	O
cost	O
-	O
effectiveness	O
,	O
and	O
(	O
iv	O
)	O
interpretation	O
of	I:C3526596
results	I:C3526596
.	O

The	O
recommendations	O
were	O
developed	O
by	O
a	O
multidisciplinary	O
working	O
group	I:C1883562
based	O
on	O
the	O
available	O
evidence	O
and	O
consensus	O
from	O
focused	O
discussions	O
for	O
(	O
i	O
)	O
identification	O
of	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
)	O
as	O
the	O
cause	O
of	O
dementia	O
,	O
(	O
ii	O
)	O
prediction	O
of	O
rate	O
of	O
decline	O
,	O
(	O
iii	O
)	O
cost	O
-	O
effectiveness	O
,	O
and	O
(	O
iv	O
)	O
interpretation	O
of	I:C3526596
results	I:C3526596
.	O

The	O
recommendations	O
were	O
developed	O
by	O
a	O
multidisciplinary	O
working	O
group	I:C1883562
based	O
on	O
the	O
available	O
evidence	O
and	O
consensus	O
from	O
focused	O
discussions	O
for	O
(	O
i	O
)	O
identification	O
of	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
as	O
the	O
cause	O
of	O
dementia	B:C0497327
,	O
(	O
ii	O
)	O
prediction	O
of	O
rate	O
of	O
decline	O
,	O
(	O
iii	O
)	O
cost	O
-	O
effectiveness	O
,	O
and	O
(	O
iv	O
)	O
interpretation	O
of	I:C3526596
results	I:C3526596
.	O

The	O
recommendations	O
were	O
developed	O
by	O
a	O
multidisciplinary	O
working	O
group	I:C1883562
based	O
on	O
the	O
available	O
evidence	O
and	O
consensus	O
from	O
focused	O
discussions	O
for	O
(	O
i	O
)	O
identification	O
of	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
as	O
the	O
cause	O
of	O
dementia	O
,	O
(	O
ii	O
)	O
prediction	O
of	O
rate	O
of	O
decline	B:C0234985
,	O
(	O
iii	O
)	O
cost	O
-	O
effectiveness	O
,	O
and	O
(	O
iv	O
)	O
interpretation	O
of	I:C3526596
results	I:C3526596
.	O

The	O
recommendations	O
were	O
developed	O
by	O
a	O
multidisciplinary	O
working	O
group	I:C1883562
based	O
on	O
the	O
available	O
evidence	O
and	O
consensus	O
from	O
focused	O
discussions	O
for	O
(	O
i	O
)	O
identification	O
of	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
(	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
)	O
as	O
the	O
cause	O
of	O
dementia	O
,	O
(	O
ii	O
)	O
prediction	O
of	O
rate	O
of	O
decline	O
,	O
(	O
iii	O
)	O
cost	O
-	O
effectiveness	O
,	O
and	O
(	O
iv	O
)	O
interpretation	B:C3526596
of	I:C3526596
results	I:C3526596
.	O

The	O
working	B:C1883562
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	O
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	B:C0007806
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	O
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	O
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	B:C0005516
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	O
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	B:C0008972
evaluation	O
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	B:C0220825
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	O
,	O
particularly	O
in	O
uncertain	B:C0087130
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	O
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	O
.	O

The	O
working	O
group	I:C1883562
found	O
sufficient	O
evidence	O
to	O
support	O
a	O
recommendation	O
to	O
use	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
as	O
a	O
supplement	O
to	O
clinical	O
evaluation	O
,	O
particularly	O
in	O
uncertain	O
and	O
atypical	O
cases	O
,	O
to	O
identify	O
or	O
exclude	O
Alzheimer	O
's	I:C0002395
disease	I:C0002395
as	O
the	O
cause	O
of	O
dementia	B:C0497327
.	O

Because	O
of	O
insufficient	O
evidence	O
,	O
it	O
was	O
uncertain	B:C0087130
whether	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
outperform	O
imaging	O
biomarkers	I:C0005516
.	O

Because	O
of	O
insufficient	O
evidence	O
,	O
it	O
was	O
uncertain	O
whether	O
cerebrospinal	B:C0007806
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
outperform	O
imaging	O
biomarkers	I:C0005516
.	O

Because	O
of	O
insufficient	O
evidence	O
,	O
it	O
was	O
uncertain	O
whether	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	B:C0002395
's	I:C0002395
disease	I:C0002395
biomarkers	O
outperform	O
imaging	O
biomarkers	I:C0005516
.	O

Because	O
of	O
insufficient	O
evidence	O
,	O
it	O
was	O
uncertain	O
whether	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	B:C0005516
outperform	O
imaging	O
biomarkers	I:C0005516
.	O

Because	O
of	O
insufficient	O
evidence	O
,	O
it	O
was	O
uncertain	O
whether	O
cerebrospinal	O
fluid	I:C0007806
Alzheimer	O
's	I:C0002395
disease	I:C0002395
biomarkers	O
outperform	O
imaging	B:C0005516
biomarkers	I:C0005516
.	O

Operational	O
recommendations	O
for	O
the	O
interpretation	O
of	O
ambiguous	O
cerebrospinal	B:C0007806
fluid	I:C0007806
biomarker	O
results	O
were	O
also	O
provided	O
.	O

Operational	O
recommendations	O
for	O
the	O
interpretation	O
of	O
ambiguous	O
cerebrospinal	O
fluid	I:C0007806
biomarker	B:C0005516
results	O
were	O
also	O
provided	O
.	O

